Skip to main content

Faculty of Health and Life Sciences

Dr Matthew Steward

Dr Matthew Steward

Clinical PhD Fellow

 M.Steward2@exeter.ac.uk

 Geoffrey Pope 

 

Geoffrey Pope Building, University of Exeter , Stocker Road, Exeter, EX4 4QD, UK


Overview

I am a Clinical PhD Fellow at the MRC Centre for Medical Mycology within the Cook group, co-supervised by Professor Scotton & Professor Gibbons. My PhD examines how Aspergillus fumigatus drives airway inflammation, how innate immune cell responses are affected, and how the human epithelium regulates this process. My research aims to utilise patient airway samples to answer these questions, establishing a biobank of research samples for further translational work in the South West. 

By training, I am a Specialty Registrar in Respiratory Medicine with research interests in fungal immunology, and airway & interstitial lung diseases.

Qualifications

BMBS MSc MRCP MAcadMEd

Research group links

Back to top


Publications

Journal articles

RECOVERY Collaborative Group, Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, Emberson JR, Stewart R, Prudon B, et al (2024). Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nat Commun, 15(1). Abstract.  Author URL.
Tansley SL, McMorrow F, Cotton CV, Adamali H, Barratt SL, Betteridge ZE, Perurena-Prieto J, Gibbons MA, Kular R, Loganathan A, et al (2024). Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with “idiopathic” interstitial lung disease. Clinical Immunology, 262 Abstract.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abbott A, et al (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401(10387), 1499-1507. Abstract.
Steward M, Thould H, Myat Noe Khin A, Gibbons MA (2023). Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis: a Review. Immunology and Allergy Clinics of North America, 43(2), 379-388.
Mikolasch TA, George PM, Sahota J, Nancarrow T, Barratt SL, Woodhead FA, Kouranos V, Cope VSA, Creamer AW, Fidan S, et al (2023). Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis. EClinicalMedicine, 55 Abstract.  Author URL.
Steward M, Sheth S (2023). Regular formoterol plus inhaled corticosteroid vs. salmeterol plus inhaled corticosteroid for asthma. Clin Exp Allergy, 53(5), 491-494.  Author URL.
Steward M, Dickson C (2023). Sonography Endobronchial Assessment, Protocols, and Interpretation. Abstract.
Steward M, Hall A (2022). A man with a cavitating lung lesion. BMJ, 377  Author URL.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N, Abdelaziz A, Abdelfattah M, et al (2022). Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399(10320), 143-151. Abstract.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H, Abbott A, Abbott A, et al (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet, 400(10349), 359-368. Abstract.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N, Abdelaziz A, Abdelfattah M, et al (2022). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399(10325), 665-676. Abstract.
Steward M (2022). Journal club. THORAX, 77(8), 844-844.  Author URL.
Melhorn J, Achaiah A, Conway FM, Thompson EMF, Skyllberg EW, Durrant J, Hasan NA, Madani Y, Naran P, Vijayakumar B, et al (2022). Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? the results of the United Kingdom (POETIC) survey. Eur Respir J, 60(3). Abstract.  Author URL.
Steward M, Yu JH, Gibbons MA (2022). Sjögren's syndrome as a cause of both lymphoid interstitial pneumonia and light chain deposition disease in a single patient. BMJ Case Rep, 15(6). Abstract.  Author URL.
Only GA (2021). Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. LANCET RESPIRATORY MEDICINE, 9(12), 1419-1426.  Author URL.
Steward M, Hall A, Sayers R, Dickson C (2021). Platypnoea-orthodeoxia syndrome due to a right-to-left interatrial shunt following pneumonectomy. BMJ Case Rep, 14(10). Abstract.  Author URL.
Steward M, Pearce C, Powari M, Bakere H (2021). Pleural malignant mesothelioma with metastatic deposition in the tongue. BMJ Case Rep, 14(6). Abstract.  Author URL.
Barratt SL, Creamer AW, Adamali HI, Duckworth A, Fallon J, Fidan S, Nancarrow T, Wollerton R, Steward M, Gooptu B, et al (2021). Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study. BMJ Open Respir Res, 8(1). Abstract.  Author URL.
(2020). Poster Abstracts. International Journal of Rheumatic Diseases, 23(S1), 109-353.
Steward M, Lee WP, Ediriweera A, Savanovic-Abel O (2019). 19. A case of giant cell arteritis (GCA) co-existent with systemic lupus erythematosus (SLE)/rheumatoid arthritis (RA) overlap syndrome. Rheumatology Advances in Practice, 3(Supplement_1).

Conferences

Steward M, Yu JH, Sayers R, Powari M, Spiers A, Lines S, Mandizha J, Gibbons MA (2022). Co-existent Lymphoid Interstitial Pneumonia and Light Chain Deposition Disease in a Patient with Sjogren's Syndrome.  Author URL.
Mandizha J, Gibbons M, Lines S, Brown G, Ana Jorge Da Ponte A, Duckworth A, Shuttleworth R, Scotton C, Russell A, Crosby M, et al (2022). Experiences of home-monitoring in patients with Interstitial Lung Disease (ILD): an exploratory, qualitative study. European Respiratory Society Congress. 4th - 6th Sep 2022.
Mandizha J, Duckworth A, Almond H, Brown G, Lines S, Jorge Da Ponte, A, Shuttleworth R, Lanario J, Seward M, Sayers R, et al (2022). Modification of the Rheumatoid Arthritis (RA) Patient Reported Experience Measure (PREM) for patients with Interstitial Lung Disease (ILD). European Respiratory Society Congress 2022. 4th - 6th Sep 2022. Abstract.
Raman L, Stewart I, Barratt S, Chua F, Chaudhuri N, Crawshaw A, Gibbons M, Hogben C, Hoyles R, Kouranos V, et al (2022). Nintedanib for progressive pulmonary fibrosis: 12-month outcome data from a multicentre observational study.  Author URL.
Steward M, Bakere HG, Burden TG (2021). THORACIC ULTRASOUND ON THE RESPIRATORY POST-TAKE WARD ROUND: ASSESSING THE IMPACT ON CLINICAL DECISION-MAKING AND THE PATIENT JOURNEY.  Author URL.
Ediriweera A, Lee WP, Steward M, Savanovic-Abel O (2020). EVALUATION OF JOINT RHEUMATOLOGY/RADIOLOGY MDT OUTCOMES & THEIR IMPACT ON RHEUMATOLOGY SERVICE.  Author URL.

Back to top


Edit Profile